Abstract
During the course of malignancies of nearly all tumor entities the urogenital organs are frequently influenced. The resulting disorders are subsumed under the term"urogenital symptoms". Especially with the goal of improving quality of life these symptoms have to be treated with respect. In addition further therapeutic measures, e.g. the application of a palliative chemotherapy, makes an unobstructed urinary excretion necessary. This article gives an overview of the indications for treating urogenital symptoms and contrasts different therapy concepts.
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / therapeutic use
-
Early Diagnosis
-
Female
-
Female Urogenital Diseases / diagnosis
-
Female Urogenital Diseases / psychology
-
Female Urogenital Diseases / therapy*
-
Humans
-
Hydronephrosis / diagnosis
-
Hydronephrosis / psychology
-
Hydronephrosis / therapy
-
Male
-
Male Urogenital Diseases / diagnosis
-
Male Urogenital Diseases / psychology
-
Male Urogenital Diseases / therapy*
-
Palliative Care*
-
Quality of Life
-
Splints
-
Ureteral Obstruction / diagnosis
-
Ureteral Obstruction / psychology
-
Ureteral Obstruction / therapy
-
Urinary Catheterization
-
Urination Disorders / diagnosis
-
Urination Disorders / psychology
-
Urination Disorders / therapy
-
Urogenital Neoplasms / complications*
-
Urogenital Neoplasms / psychology
-
Urogenital Neoplasms / therapy